New Orleans, LA, United States of America

Lee Roy Morgan

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents, primarily in Anti-Cancer Agents. Top assignees: Dekk-Tec, Inc., Bo-Dekk Ventures, Ltd., Dekk-Tek, Inc.. Active years: 1987-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee Roy Morgan. Retrieved from https://idiyas.com/inventor/lee-roy-morgan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 1.2

ph-index = 10

Forward Citations = 319(Granted Patents)

Location History:

Gaithersburg, MD (US) (2016)
New Orleans, LA (US) (1987 - 2020)

Company Filing History:

Bo-Dekk Ventures, Ltd.

Omnitron International, Inc.

patents

5. 1 out of 12

Ziopharm Oncology, Inc.

patents

6. 8 out of 834,570

Other

patents

Years Active: 1987-2020

Loading Chart...

Areas of Expertise:

Demethylpenclomedine

Isophosphoramide Mustard

Anti-Tumor Agents

Boron Difluoride Compounds

Photodynamic Therapy

Tumor Response Prediction

In Situ Radiotherapy

Indacene Compounds

Dermal Inflammations

Antiestrogenic Hydrazones

Chemical Ulcers Treatment

Herpes Virus Infections

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10772878 - Demethylpenclomedine analogs and their use as anti-cancer agents (2020-09-15),

2. 9884051 - Demethylpenclomedine analogs and their use as anti-cancer agents (2018-02-06),

3. 9422241 - Demethylpenclomedine analogs and their use as anti-cancer agents (2016-08-23),

4. 9421031 - Scalpel blade holder (2016-08-23),

5. 9346836 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2016-05-24),

6. 8795659 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2014-08-05),

7. 8361992 - Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents (2013-01-29),

8. 8232262 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents (2012-07-31),

9. 8124596 - Demethylpenclomedine analogs and their use as anti-cancer agents (2012-02-28),

10. 7678778 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2010-03-16),

11. 5446157 - Boron difluoride compounds useful in photodynamic therapy and production (1995-08-29),

12. 5270172 - Method to predict tumor response to therapy (1993-12-14),

13. 5189029 - Indacene compounds and methods for using the same (1993-02-23),

14. 5183455 - Apparatus for in situ radiotherapy (1993-02-02),

15. 4976680 - Apparatus for in situ radiotherapy (1990-12-11),

Title: Lee Roy Morgan: Innovator and Contributor to Cancer Research

Introduction: Lee Roy Morgan, based in New Orleans, LA, is a prominent inventor with a remarkable portfolio of 20 patents. His groundbreaking work primarily focuses on the development of novel compounds with potential applications in the medical field, particularly in cancer treatment.

Latest Patents: One of Lee Roy Morgan's latest innovations is centered around demethylpenclomedine analogs and their use as anti-cancer agents. This patent disclosure encompasses novel compounds designed to tackle hyperproliferative disorders. Additionally, it includes descriptions of pharmaceutical compositions and methodologies for utilizing these analogs in clinical applications. The potential impact of this work could be significant in advancing cancer therapies.

Career Highlights: Throughout his career, Lee Roy Morgan has made substantial contributions to the field of pharmaceuticals and biotechnology. His inventive spirit has led to numerous advancements, with each patent reflecting his dedication to improving medical treatments and outcomes.

Collaborations: Collaboration has been a vital aspect of Lee Roy Morgan's career. He has worked alongside notable individuals such as Joseph H. Boyer and Michael H. Hayman, pooling their expertise to enhance the scope and efficacy of their research efforts. These partnerships have facilitated the development of innovative solutions in the fight against cancer.

Conclusion: Lee Roy Morgan’s contributions to innovation underscore the importance of creativity and collaboration in the fields of medicine and technology. With 20 patents to his name, he continues to pave the way for future advancements in cancer treatment, proving that dedicated inventors can have a lasting impact on global health care.

Profile summary based on public USPTO records.